Literature DB >> 10759248

Mechanisms of Helicobacter pylori-induced rat gastric mucosal microcirculatory disturbances in vivo.

N Kalia1, K D Bardhan, M W Reed, S Jacob, N J Brown.   

Abstract

The exact mechanisms by which Helicobacter pylori infection results in gastric mucosal injury are unclear. However, it has been demonstrated that surface protein extracts of the bacterium can induce a number of disturbances within the rat gastric mucosal microcirculation, including platelet aggregation and macromolecular leakage (MML) of labeled albumin. This study aimed to determine the mechanisms involved in inducing these events using the technique of fluorescent in vivo microscopy. Male Wistar rats were pretreated with either ketotifen, a mast cell stabilizer (1 mg/kg), pyrilamine, an H1-receptor antagonist (30 mg/kg), hexanolamine-PAF, a PAF-receptor antagonist (10 microg/kg), L-arginine, the nitric oxide precursor (300 mg/kg) or vehicle, saline. Then 0.5 ml of H. pylori extract was administered to the exteriorized gastric mucosa of the anesthetized rat. Alterations in fluorescein-labeled albumin leak, vessel diameters, and acridine red-labeled leukocyte and platelet activity were determined over a 2-hr period. Saline pretreated animals demonstrated significant MML with a peak at 5 min (11%, P<0.02). This was prevented with ketotifen and pyrilamine, but not with hexanolamine-PAF (17.5%, P<0.05) and L-arginine (13%, P<0.05). Significant numbers of platelet emboli and thrombi were observed within mucosal capillaries and postcapillary venules with vehicle pretreatment; this was prevented with hexanolamine-PAF and L-arginine, but not with ketotifen and pyrilamine. In conclusion, these studies demonstrate that more than one mediator is involved in inducing the rat gastric mucosal microcirculatory disturbances associated with H. pylori administration. Mast cells and histamine are linked to MML, with PAF, probably not derived from mast cells, involved in platelet activation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10759248     DOI: 10.1023/a:1005456029396

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  35 in total

1.  Ethanol-induced injury to the rat gastric mucosa. Role of neutrophils and xanthine oxidase-derived radicals.

Authors:  P R Kvietys; B Twohig; J Danzell; R D Specian
Journal:  Gastroenterology       Date:  1990-04       Impact factor: 22.682

Review 2.  Perspectives in platelet-activating factor research.

Authors:  P Braquet; L Touqui; T Y Shen; B B Vargaftig
Journal:  Pharmacol Rev       Date:  1987-06       Impact factor: 25.468

3.  Studies on gastric mucosal microcirculation. 1. The nature of regional variations induced by ethanol injury.

Authors:  N Kalia; N J Brown; S Jacob; M W Reed; K D Bardhan
Journal:  Gut       Date:  1997-01       Impact factor: 23.059

4.  Gastric ulceration induced by nonsteroidal anti-inflammatory drugs is a neutrophil-dependent process.

Authors:  J L Wallace; C M Keenan; D N Granger
Journal:  Am J Physiol       Date:  1990-09

5.  Soluble surface proteins from Helicobacter pylori activate monocytes/macrophages by lipopolysaccharide-independent mechanism.

Authors:  U E Mai; G I Perez-Perez; L M Wahl; S M Wahl; M J Blaser; P D Smith
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

Review 6.  Histopathology of gastroduodenal inflammation: the impact of Helicobacter pylori.

Authors:  J I Wyatt
Journal:  Histopathology       Date:  1995-01       Impact factor: 5.087

7.  Potent ulcerogenic actions of platelet-activating factor on the stomach.

Authors:  A C Rosam; J L Wallace; B J Whittle
Journal:  Nature       Date:  1986 Jan 2-8       Impact factor: 49.962

8.  Helicobacter pylori secretes a chemotactic factor for monocytes and neutrophils.

Authors:  P M Craig; M C Territo; W E Karnes; J H Walsh
Journal:  Gut       Date:  1992-08       Impact factor: 23.059

9.  Interaction of NSAIDs and Helicobacter pylori on gastrointestinal injury and prostaglandin production: a controlled double-blind trial.

Authors:  L Laine; F Cominelli; R Sloane; V Casini-Raggi; M Marin-Sorensen; W M Weinstein
Journal:  Aliment Pharmacol Ther       Date:  1995-04       Impact factor: 8.171

10.  Mechanisms involved in Helicobacter pylori-induced inflammation.

Authors:  N Yoshida; D N Granger; D J Evans; D G Evans; D Y Graham; D C Anderson; R E Wolf; P R Kvietys
Journal:  Gastroenterology       Date:  1993-11       Impact factor: 22.682

View more
  4 in total

1.  Curcumin suppresses gastric NF-kappaB activation and macromolecular leakage in Helicobacter pylori-infected rats.

Authors:  Kawiya Sintara; Duangporn Thong-Ngam; Suthiluk Patumraj; Naruemon Klaikeaw; Tanittha Chatsuwan
Journal:  World J Gastroenterol       Date:  2010-08-28       Impact factor: 5.742

2.  Helicobacter pylori neutrophil-activating protein induces release of histamine and interleukin-6 through G protein-mediated MAPKs and PI3K/Akt pathways in HMC-1 cells.

Authors:  Chung-Che Tsai; Ting-Yu Kuo; Zhi-Wei Hong; Ying-Chieh Yeh; Kuo-Shun Shih; Shin-Yi Du; Hua-Wen Fu
Journal:  Virulence       Date:  2015-09-16       Impact factor: 5.882

3.  Toxigenic Helicobacter pylori induces changes in the gastric mucosal microcirculation in rats.

Authors:  N Kalia; K D Bardhan; J C Atherton; N J Brown
Journal:  Gut       Date:  2002-11       Impact factor: 23.059

4.  Impact of acid secretion, gastritis, and mucus thickness on gastric transfer of antibiotics in rats.

Authors:  P V Sherwood; J I D Wibawa; J C Atherton; N Jordan; D Jenkins; D A Barrett; P N Shaw; R C Spiller
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.